Caddie’s CRO4AI: Advancing AI Clinical Studies for FDA Clearance
🚀 Revolutionizing AI Clinical Studies with Caddie’s CRO4AI 🚀
Caddie has secured and confirmed a large dataset of high-resolution incidental-finding (non-screening) nodule CT cases for independent multi-reader multi-case (MRMC) clinical studies—paving the way for FDA clearance.
These US-based anonymized CT cases (non-contrast thin-slice) include nodules of varying sizes, locations, and boundaries pre-annotated by SIFT. Unlike other datasets, these cases have never been used to train any AI models, ensuring unbiased and independent validation.
✅ What CRO4AI Offers:
🔹 SIFT-Based Case Selection – High-quality, unbiased CT cases
🔹 Study Analysis & Data Management – Streamlined clinical trials
🔹 Accelerated FDA Success – Trusted by 15+ AI-driven clinical studies
💡 Why Choose Caddie?
Caddie’s expertise in computer-aided detection (CAD) and computer-aided diagnosis (CADx) has successfully supported multiple FDA PMA/510k submissions. If you’re developing AI for medical imaging, Caddie’s CRO4AI tool is your ultimate clinical study accelerator.
📩 Contact us today to learn more about CRO4AI and accelerate your AI’s path to FDA clearance!
🌐 Visit us at https://caddieai.io/
📧 Get in touch: [email protected]
🔔 Subscribe for more AI & medical imaging insights!
#CRO4AI #MedicalAI #FDAApproval #ArtificialIntelligence #Radiology #ClinicalStudies #AIinHealthcare #CAD #CADx #CTScan #MedicalImaging